|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Umang_Vohra
|
|
gptkbp:country
|
gptkb:India
|
|
gptkbp:foundedBy
|
gptkb:Khwaja_Abdul_Hamied
|
|
gptkbp:foundedYear
|
1935
|
|
gptkbp:hasResearchCenter
|
gptkb:India
gptkb:South_Africa
gptkb:United_States
|
|
gptkbp:headquartersLocation
|
gptkb:Mumbai
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
CIPLA
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:ISIN
|
INE059A01026
|
|
gptkbp:listedOn
|
gptkb:NIFTY_50
|
|
gptkbp:manufacturingFacilities
|
gptkb:India
gptkb:South_Africa
gptkb:United_States
|
|
gptkbp:market
|
Over 80 countries
|
|
gptkbp:notableFor
|
Affordable HIV/AIDS drugs
Global pharmaceutical exports
|
|
gptkbp:numberOfEmployees
|
25000+
|
|
gptkbp:products
|
Over-the-counter medicines
Active pharmaceutical ingredients
Generic drugs
|
|
gptkbp:revenue
|
INR 21,763 crore (FY 2023)
|
|
gptkbp:stockExchange
|
gptkb:NSE
BSE
|
|
gptkbp:stockSymbol
|
gptkb:CIPLA
|
|
gptkbp:subsidiary
|
gptkb:Cipla_Medpro
gptkb:Cipla_USA_Inc.
|
|
gptkbp:website
|
https://www.cipla.com/
|
|
gptkbp:bfsParent
|
gptkb:Cipla_Limited
|
|
gptkbp:bfsLayer
|
7
|